NCT07204795 Effect of Preoperative Oral Carbohydrate Drink on ObsQoR-10 Score After Elective Cesarean Under Neuraxial Anesthesia
| NCT ID | NCT07204795 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ataturk University |
| Condition | ObsQor-10 |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-05-20 |
| Primary Completion | 2026-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-05-20 with a primary completion date of 2026-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to determine whether a preoperative oral carbohydrate-rich clear drink can improve recovery in women undergoing elective cesarean section under neuraxial anesthesia. The main outcomes it aims to answer are: Primary Outcome: Does the carbohydrate drink improve ObsQoR-10 scores at 24 and 48 hours postoperatively? Secondary Outcomes: Does it reduce patients' hunger, thirst, and anxiety levels? Researchers will compare patients receiving a 400 ml oral carbohydrate-rich clear drink 2 hours before surgery (Group A) to those receiving 400 ml distilled water (Group B), to assess differences in recovery and comfort. Participants will: Be randomized into two equal groups (n=50 each) using a computer-generated randomization table Receive standardized anesthesia and postoperative analgesia
Eligibility Criteria
Inclusion Criteria: Age ≥18 years Scheduled for elective cesarean section under neuraxial anesthesia Gestational age ≥37 weeks Exclusion Criteria: Contraindication to neuraxial anesthesia Age \<18 years Refusal to participate in the study Obesity Hiatal hernia Intestinal obstruction Gastroesophageal reflux disease (GERD) Diabetes mellitus Fetal anomalies Eclampsia or preeclampsia Substance abuse Chronic pain conditions
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07204795 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying ObsQor-10. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07204795 currently recruiting?
Yes, NCT07204795 is actively recruiting participants. Contact the research team at adostbil@hotmail.com for enrollment information.
Where is the NCT07204795 trial being conducted?
This trial is being conducted at Erzurum, Turkey (Türkiye).
Who is sponsoring the NCT07204795 clinical trial?
NCT07204795 is sponsored by Ataturk University. The trial plans to enroll 100 participants.